0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalamine Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-27A8791
Home | Market Reports
Global Mesalamine Market Outlook 2022
BUY CHAPTERS

Global Mesalamine Market Research Report 2026

Code: QYRE-Auto-27A8791
Report
2026-02-26
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mesalamine Market Size

The global Mesalamine market was valued at US$ 193 million in 2025 and is anticipated to reach US$ 256 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Mesalamine Market

Mesalamine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mesalamine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Mesalamine also known as mesalazine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
In 2024, global Mesalamine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
This report delivers a comprehensive overview of the global Mesalamine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mesalamine. The Mesalamine market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mesalamine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mesalamine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Mesalamine Market Report

Report Metric Details
Report Name Mesalamine Market
Accounted market size in 2025 US$ 193 million
Forecasted market size in 2032 US$ 256 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
by Application
  • Tablets
  • Capsules
  • Granule
  • Suppository
  • Enema
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Mesalamine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Mesalamine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Mesalamine Market growing?

Ans: The Mesalamine Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Mesalamine Market size in 2032?

Ans: The Mesalamine Market size in 2032 will be US$ 256 million.

What is the market share of major companies in Mesalamine Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalamine Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalamine Market report?

Ans: The main players in the Mesalamine Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu)

What are the Application segmentation covered in the Mesalamine Market report?

Ans: The Applications covered in the Mesalamine Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalamine Market report?

Ans: The Types covered in the Mesalamine Market report are Purity ≥ 97%, Purity ≥ 98%, Purity ≥ 99%

1 Mesalamine Market Overview
1.1 Product Definition
1.2 Mesalamine by Type
1.2.1 Global Mesalamine Market Value by Type: 2025 vs 2032
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine by Application
1.3.1 Global Mesalamine Market Value by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2021–2032
1.4.2 Global Mesalamine Sales 2021–2032
1.4.3 Global Mesalamine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mesalamine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mesalamine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mesalamine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mesalamine, Product Types and Applications
2.7 Global Key Manufacturers of Mesalamine, Date of Entry into the Industry
2.8 Global Mesalamine Market Competitive Situation and Trends
2.8.1 Global Mesalamine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mesalamine Players Market Share by Revenue
2.8.3 Global Mesalamine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalamine Market Scenario by Region
3.1 Global Mesalamine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mesalamine Sales by Region: 2021–2032
3.2.1 Global Mesalamine Sales by Region: 2021–2026
3.2.2 Global Mesalamine Sales by Region: 2027–2032
3.3 Global Mesalamine Revenue by Region: 2021–2032
3.3.1 Global Mesalamine Revenue by Region: 2021–2026
3.3.2 Global Mesalamine Revenue by Region: 2027–2032
3.4 North America Mesalamine Market Facts & Figures by Country
3.4.1 North America Mesalamine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mesalamine Sales by Country (2021–2032)
3.4.3 North America Mesalamine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mesalamine Market Facts & Figures by Country
3.5.1 Europe Mesalamine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mesalamine Sales by Country (2021–2032)
3.5.3 Europe Mesalamine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalamine Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalamine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mesalamine Sales by Region (2021–2032)
3.6.3 Asia Pacific Mesalamine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mesalamine Market Facts & Figures by Country
3.7.1 Latin America Mesalamine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mesalamine Sales by Country (2021–2032)
3.7.3 Latin America Mesalamine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalamine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mesalamine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mesalamine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalamine Sales by Type (2021–2032)
4.1.1 Global Mesalamine Sales by Type (2021–2026)
4.1.2 Global Mesalamine Sales by Type (2027–2032)
4.1.3 Global Mesalamine Sales Market Share by Type (2021–2032)
4.2 Global Mesalamine Revenue by Type (2021–2032)
4.2.1 Global Mesalamine Revenue by Type (2021–2026)
4.2.2 Global Mesalamine Revenue by Type (2027–2032)
4.2.3 Global Mesalamine Revenue Market Share by Type (2021–2032)
4.3 Global Mesalamine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mesalamine Sales by Application (2021–2032)
5.1.1 Global Mesalamine Sales by Application (2021–2026)
5.1.2 Global Mesalamine Sales by Application (2027–2032)
5.1.3 Global Mesalamine Sales Market Share by Application (2021–2032)
5.2 Global Mesalamine Revenue by Application (2021–2032)
5.2.1 Global Mesalamine Revenue by Application (2021–2026)
5.2.2 Global Mesalamine Revenue by Application (2027–2032)
5.2.3 Global Mesalamine Revenue Market Share by Application (2021–2032)
5.3 Global Mesalamine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Company Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 PharmaZell Mesalamine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Company Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Syntese A/S Mesalamine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Company Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cambrex Corporation Mesalamine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Company Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Divis Laboratories Mesalamine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Company Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chemi SpA Mesalamine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Company Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ipca Laboratories Mesalamine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.7.1 Hangzhou Brother Company Information
6.7.2 Hangzhou Brother Description and Business Overview
6.7.3 Hangzhou Brother Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hangzhou Brother Mesalamine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Company Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Company Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lasa Loboratory Mesalamine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Company Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Company Information
6.11.2 Erregierre SpA Description and Business Overview
6.11.3 Erregierre SpA Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Erregierre SpA Mesalamine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Company Information
6.12.2 CTX Lifescience Description and Business Overview
6.12.3 CTX Lifescience Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 CTX Lifescience Mesalamine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Company Information
6.13.2 Ishita Active Pharma Ingredients Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Company Information
6.14.2 YC Biotech (Jiangsu) Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalamine Industry Chain Analysis
7.2 Mesalamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalamine Production Mode & Process Analysis
7.4 Mesalamine Sales and Marketing
7.4.1 Mesalamine Sales Channels
7.4.2 Mesalamine Distributors
7.5 Mesalamine Customer Analysis
8 Mesalamine Market Dynamics
8.1 Mesalamine Industry Trends
8.2 Mesalamine Market Drivers
8.3 Mesalamine Market Challenges
8.4 Mesalamine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mesalamine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Mesalamine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Mesalamine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Mesalamine Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Mesalamine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Mesalamine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Mesalamine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Mesalamine Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Mesalamine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Mesalamine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Mesalamine, Product Types and Applications
 Table 12. Global Key Manufacturers of Mesalamine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mesalamine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mesalamine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Mesalamine Sales by Region (Tons), 2021–2026
 Table 18. Global Mesalamine Sales Market Share by Region (2021–2026)
 Table 19. Global Mesalamine Sales by Region (Tons), 2027–2032
 Table 20. Global Mesalamine Sales Market Share by Region (2027–2032)
 Table 21. Global Mesalamine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Mesalamine Revenue Market Share by Region (2021–2026)
 Table 23. Global Mesalamine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Mesalamine Revenue Market Share by Region (2027–2032)
 Table 25. North America Mesalamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Mesalamine Sales by Country (Tons), 2021–2026
 Table 27. North America Mesalamine Sales by Country (Tons), 2027–2032
 Table 28. North America Mesalamine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Mesalamine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Mesalamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Mesalamine Sales by Country (Tons), 2021–2026
 Table 32. Europe Mesalamine Sales by Country (Tons), 2027–2032
 Table 33. Europe Mesalamine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Mesalamine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Mesalamine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Mesalamine Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Mesalamine Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Mesalamine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Mesalamine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Mesalamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Mesalamine Sales by Country (Tons), 2021–2026
 Table 42. Latin America Mesalamine Sales by Country (Tons), 2027–2032
 Table 43. Latin America Mesalamine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Mesalamine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Mesalamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Mesalamine Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Mesalamine Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Mesalamine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Mesalamine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Mesalamine Sales (Tons) by Type (2021–2026)
 Table 51. Global Mesalamine Sales (Tons) by Type (2027–2032)
 Table 52. Global Mesalamine Sales Market Share by Type (2021–2026)
 Table 53. Global Mesalamine Sales Market Share by Type (2027–2032)
 Table 54. Global Mesalamine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Mesalamine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Mesalamine Revenue Market Share by Type (2021–2026)
 Table 57. Global Mesalamine Revenue Market Share by Type (2027–2032)
 Table 58. Global Mesalamine Price (US$/kg) by Type (2021–2026)
 Table 59. Global Mesalamine Price (US$/kg) by Type (2027–2032)
 Table 60. Global Mesalamine Sales (Tons) by Application (2021–2026)
 Table 61. Global Mesalamine Sales (Tons) by Application (2027–2032)
 Table 62. Global Mesalamine Sales Market Share by Application (2021–2026)
 Table 63. Global Mesalamine Sales Market Share by Application (2027–2032)
 Table 64. Global Mesalamine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Mesalamine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Mesalamine Revenue Market Share by Application (2021–2026)
 Table 67. Global Mesalamine Revenue Market Share by Application (2027–2032)
 Table 68. Global Mesalamine Price (US$/kg) by Application (2021–2026)
 Table 69. Global Mesalamine Price (US$/kg) by Application (2027–2032)
 Table 70. PharmaZell Company Information
 Table 71. PharmaZell Description and Business Overview
 Table 72. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. PharmaZell Mesalamine Product
 Table 74. PharmaZell Recent Developments/Updates
 Table 75. Syntese A/S Company Information
 Table 76. Syntese A/S Description and Business Overview
 Table 77. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Syntese A/S Mesalamine Product
 Table 79. Syntese A/S Recent Developments/Updates
 Table 80. Cambrex Corporation Company Information
 Table 81. Cambrex Corporation Description and Business Overview
 Table 82. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Cambrex Corporation Mesalamine Product
 Table 84. Cambrex Corporation Recent Developments/Updates
 Table 85. Divis Laboratories Company Information
 Table 86. Divis Laboratories Description and Business Overview
 Table 87. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Divis Laboratories Mesalamine Product
 Table 89. Divis Laboratories Recent Developments/Updates
 Table 90. Chemi SpA Company Information
 Table 91. Chemi SpA Description and Business Overview
 Table 92. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Chemi SpA Mesalamine Product
 Table 94. Chemi SpA Recent Developments/Updates
 Table 95. Ipca Laboratories Company Information
 Table 96. Ipca Laboratories Description and Business Overview
 Table 97. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Ipca Laboratories Mesalamine Product
 Table 99. Ipca Laboratories Recent Developments/Updates
 Table 100. Hangzhou Brother Company Information
 Table 101. Hangzhou Brother Description and Business Overview
 Table 102. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Hangzhou Brother Mesalamine Product
 Table 104. Hangzhou Brother Recent Developments/Updates
 Table 105. Lianyungang Fengheng Biopharm Company Information
 Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
 Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
 Table 109. Lianyungang Fengheng Biopharm Recent Developments/Updates
 Table 110. Lasa Loboratory Company Information
 Table 111. Lasa Loboratory Description and Business Overview
 Table 112. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Lasa Loboratory Mesalamine Product
 Table 114. Lasa Loboratory Recent Developments/Updates
 Table 115. Corden Pharma Bergamo Company Information
 Table 116. Corden Pharma Bergamo Description and Business Overview
 Table 117. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Corden Pharma Bergamo Mesalamine Product
 Table 119. Corden Pharma Bergamo Recent Developments/Updates
 Table 120. Erregierre SpA Company Information
 Table 121. Erregierre SpA Description and Business Overview
 Table 122. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. Erregierre SpA Mesalamine Product
 Table 124. Erregierre SpA Recent Developments/Updates
 Table 125. CTX Lifescience Company Information
 Table 126. CTX Lifescience Description and Business Overview
 Table 127. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. CTX Lifescience Mesalamine Product
 Table 129. CTX Lifescience Recent Developments/Updates
 Table 130. Ishita Active Pharma Ingredients Company Information
 Table 131. Ishita Active Pharma Ingredients Description and Business Overview
 Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 133. Ishita Active Pharma Ingredients Mesalamine Product
 Table 134. Ishita Active Pharma Ingredients Recent Developments/Updates
 Table 135. YC Biotech (Jiangsu) Company Information
 Table 136. YC Biotech (Jiangsu) Description and Business Overview
 Table 137. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 138. YC Biotech (Jiangsu) Mesalamine Product
 Table 139. YC Biotech (Jiangsu) Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Mesalamine Distributors List
 Table 143. Mesalamine Customers List
 Table 144. Mesalamine Market Trends
 Table 145. Mesalamine Market Drivers
 Table 146. Mesalamine Market Challenges
 Table 147. Mesalamine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalamine
 Figure 2. Global Mesalamine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Mesalamine Market Share by Type: 2025 & 2032
 Figure 4. Purity ≥ 97% Product Picture
 Figure 5. Purity ≥ 98% Product Picture
 Figure 6. Purity ≥ 99% Product Picture
 Figure 7. Global Mesalamine Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Mesalamine Market Share by Application: 2025 & 2032
 Figure 9. Tablets
 Figure 10. Capsules
 Figure 11. Granule
 Figure 12. Suppository
 Figure 13. Enema
 Figure 14. Others
 Figure 15. Global Mesalamine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Mesalamine Market Size (US$ Million), 2021–2032
 Figure 17. Global Mesalamine Sales (Tons), 2021–2032
 Figure 18. Global Mesalamine Average Price (US$/kg), 2021–2032
 Figure 19. Mesalamine Report Years Considered
 Figure 20. Mesalamine Sales Share by Manufacturers in 2025
 Figure 21. Global Mesalamine Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Mesalamine Players: Market Share by Revenue in Mesalamine in 2025
 Figure 23. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Mesalamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Mesalamine Sales Market Share by Country (2021–2032)
 Figure 26. North America Mesalamine Revenue Market Share by Country (2021–2032)
 Figure 27. U.S. Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Mesalamine Sales Market Share by Country (2021–2032)
 Figure 30. Europe Mesalamine Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Mesalamine Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Mesalamine Revenue Market Share by Region (2021–2032)
 Figure 38. China Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Taiwan Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Indonesia Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Thailand Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Malaysia Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Philippines Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Latin America Mesalamine Sales Market Share by Country (2021–2032)
 Figure 49. Latin America Mesalamine Revenue Market Share by Country (2021–2032)
 Figure 50. Mexico Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Brazil Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Argentina Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Mesalamine Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Mesalamine Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE Mesalamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Mesalamine by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Mesalamine by Type (2021–2032)
 Figure 60. Global Mesalamine Price (US$/kg) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Mesalamine by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Mesalamine by Application (2021–2032)
 Figure 63. Global Mesalamine Price (US$/kg) by Application (2021–2032)
 Figure 64. Mesalamine Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools